Antihypertensive Therapy With Ca2+: Antagonist Verapamil and/or ACE Inhibitor Enalapril in NIDDM Patients

C Ferrier, P Ferrari, P Weidmann, U Keller… - Diabetes …, 1991 - Am Diabetes Assoc
Objective To assess the efficacy and tolerance of a diuretic-free antihypertensive therapy
with a Ca2+ antagonist and an angiotensin-converting enzyme (ACE) inhibitor in patients …

Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients.

C Ferrier, P Ferrari, P Weidmann, U Keller… - Diabetes …, 1991 - europepmc.org
Objective To assess the efficacy and tolerance of a diuretic-free antihypertensive therapy
with a Ca2+ antagonist and an angiotensin-converting enzyme (ACE) inhibitor in patients …

[引用][C] Antihypertensive therapy with Ca2+: antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients

C FERRIER, P FERRARI, P WEIDMANN… - Diabetes …, 1991 - pascal-francis.inist.fr
Antihypertensive therapy with Ca2+ : antagonist verapamil and/or ACE inhibitor enalapril in
NIDDM patients CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients.

C Ferrier, P Ferrari, P Weidmann, U Keller… - Diabetes care, 1991 - sonar.ch
RESEARCH DESIGN AND METHODS After a 2-wk washout and a 4-wk placebo phase, 47
hypertensive patients with NIDDM randomly received verapamil or enalapril alone and, if …

Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients

C Ferrier, P Ferrari, P Weidmann, U Keller… - Diabetes …, 1991 - pubmed.ncbi.nlm.nih.gov
Objective To assess the efficacy and tolerance of a diuretic-free antihypertensive therapy
with a Ca2+ antagonist and an angiotensin-converting enzyme (ACE) inhibitor in patients …